Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 205-211

  De Gasperi, Rita ^a   Gama Sosa, Miguel Angel ^a   Patarca, Roberto ^b   Battistini, Stefania ^a   Lamoreux, Michele R ^a   Raghavan, Srinivasa ^a   Kowall, Neil W ^c   Smith, Karen Harrington ^c   Fletcher, Mary Ann ^b   Kolodny, Edwin H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; HYDROXY FATTY ACID; IMMUNOGLOBULIN G ANTIBODY; MYELIN; SULFATIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTONOMIC NEUROPATHY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MONONEUROPATHY MULTIPLEX; NEUROLOGICAL COMPLICATION; PERIPHERAL NEUROPATHY; POLYRADICULITIS; PRIORITY JOURNAL;

EID: 0030063706     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.205     Document Type: Article

References (38)

1. Simpson DM and Tagliati M: Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-785.
2. Rhodes RH: Histopathology of the central nervous system in the acquired immunodeficiency syndrome. Hum Pathol 1987;18:636-643.
3. Budka H: Neuropathology of human immunodeficiency infection. Brain Pathol 1991;1:163-175.
4. Sharer LR: Pathology of HIV infection in the central nervous system. A review. J Neuropathol Exp Neurol 1992;51:3-11.
5. Kleihues P, Lang W, Burger PC, Budka H, Vogt M, Maurer R, Luthy R, and Siegenthaler W: Progressive diffuse leukoencephalopathy in patients with acquired immunodeficiency syndrome (AIDS). Acta Neuropathol 1985;68:333-339.
6. Barnes DM: Brain damage by AIDS under active study. Science 1987;235:1574-1577.
7. Tillman M and Wigdahl B: Neuropathogenesis of human immunodeficiency virus infection. Semin Neurosci 1991;3:131-139.
8. Epstein LG and Gendelman HE: Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann Neurol 1993;33:429-436.
9. Solinger AM and Hess EV: Induction of autoantibodies by human immunodeficiency virus infection and their significance. Rheum Dis Clin North Am 1991;17:157-176.
10. Mastroianni CM, Liuzzi GM, Vullo V, Jirillo E, Delia S, and Riccio P: Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex. Mol Chem Neuropathol 1991;143:227-236.
11. Hagberg L, Norkrans G, Zanetta JP, Lehmann S, and Bergstrom T: Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection. J Neuroimmunol 1992;36:245-249.
12. Saida T, Saida K, Dorfman SH, Silberberg D, Sumner AJ, Manning MG, and Lisak RP: Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979;204:1103-1106.
13. Saida T, Saida K, Silberberg D, and Brown MJ: Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981;9:87-101.
14. Ozawa K, Saida T, Saida K, Nishitani H, and Kameyama M: In vivo CNS demyelination mediated by anti-galactocerebroside antibody. Acta Neuropathol 1989;77:621-628.
15. 14C]sulfatide) as substrate for cerebroside sulfatase assay. Anal Biochem 1980;102:313-317.
16. Hirabayashi Y, Suzuki T, Suzuki Y, Taki T, Matsumoto M, Higashi H, and Kato S: A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem 1983;94:327-330.
17. D1 in human gliomas in vitro and in vivo. J Neuropathol Exp Neurol 1991;50:756-769.
18. Fredman P, Vedeler CA, Nyland H, Aarli JA, and Svennerholm L: Antibodies in sera from patients with inflammatory demyelinating polyradiculopathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol 1991;238:75-79.
19. Quattrini A, Corbo M, Dhaliwal SK, Sadiq SA, Lugaresi A, Oliveira A, Uncini A, Abouzahr K, Miller JR, Lewis L, Estes D, Cardo L, Hays AP, and Latov N: Anti-sulfatide antibodies in neurological disease: Binding to rat dorsal root ganglia neurons. J Neurol Sci 1992;112:152-159.
20. Pestronk A, Li F, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, Yee WC, Phillips D, Peeples DM, and Winslow B: Polyneuropathy syndrome associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41: 357-362.
21. Ilyas AA, Mithen FA, Dalakas MC, Wargo M, Chen ZW, Bielory L, and Cook SD: Antibodies to sulfated glycolipid in Guillan-Barré syndrome. J Neurol Sci 1991;105:108-117.
22. Aotsuka S, Okawa-Takatsuji M, Uwatoko S, Yokohari R, Ikeda Y, and Toda G: Antibodies against sulfatide in sera from patients with autoimmune rheumatic diseases. Clin Exp Immunol 1992;87: 438-443.
23. van Vliet HHDM, Kappers-Klunne MC, van der Hel JWB, and Abels J: Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenia purpura. Br J Haematol 1987;67:103-108.
24. Kikkawa Y, Mimura A, and Inage Z: Regional distribution of sulfatide in human kidney, and anti-sulfatide antibodies in sera from patients with nephritis detected by TLC immunostaining. Nippon Jinzo Gakkai Shi 1991;33:635-642.
25. Tamaoki A and Kikkawa Y: The role of sulfatides in autoimmunity in children with various glomerular disease. Nippon Jinzo Gakkai Shi 1991;33:1045-1054.
26. Toda G, Ikeda Y, Kashiwagi M, Iwamori M, and Oka H: Hepatocyte plasma membrane glycosphingolipid reactive with the sera from patients with autoimmune chronic active hepatitis: Its identification as sulfatide. Hepatology 1990;12:664-670.
27. Buschard K, Josefsen K, Horn T, and Fredman P: Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet 1993;342:840.
28. Ryberg B: Multiple specificity of antibrain antibodies in multiple sclerosis and chronic myelopathy. J Neurol Sci 1978;38:357-382.
29. Fredman P, Mattsson K, Andersson K, Davidsson P, Ishizuka I, Jeansson S, Mansson JE, and Svennerholm, L: Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem J 1988;251:17-22.
30. Chou DKH, Ilyas AA, Evans JE, Costello C, Quarles RH, and Jungalwala FB: Structures of sulfated glucuronylglycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem 1986;261:11717-11725.
31. Ilyas AA, Cook S, Dalakas MC, and Mithen FA: Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol 1992;37:85-92.
32. Norton WT and Poduslo SE: Myelination in rat brain: Changes in myelin composition during brain maturation. J Neurochem 1973;21:759-773.
33. Ginsburg V and Roberts DD: Glycoconjugates in cell adhesion: The adhesive proteins laminins, thrombospondin, and von Willebrand's factor bind specifically to sulfated glycolipids. Biochimie 1988;70:1651-1659.
34. Zalc B, Helwig JJ, Ghandour MS, and Sarlieve L: Sulfatide in kidney: How is this lipid involved in sodium chloride transport? FEBS Lett 1978;92:92-96.
35. Craves FB, Zalc B, Leybin L, Baumann N, and Loh HH: Antibodies to cerebroside sulfate inhibit the effect of morphine and β-endorphin. Science 1980;207:75-76.
36. 4)β1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem 1990;265:2852-2855.
37. Suzuki Y, Toda Y, Tamatani T, Watanabe T, Suzuki T, Nakao T, Murase K, Kiso M, Hasegawa A, Tadano-Aritomi K, Ishizuka I, and Miyasaka M: Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain. Biochem Biophys Res Commun 1993;190: 426-434.
38. Aruffo A, Kolanus W, Walz G, Fredman P, and Seed B: CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell 1991;67:35-44.